INFLAMMATIO-2018

Dr Mamta Agarwal completed her medical graduate degree from Government Medical College, Amritsar , India in 1996. She passed her Diplomate in National Board of Examination (DNB) at Sankara Nethralaya (2002), Chennai, India. She specialized in Uveitis and Intraocular Inflammation at Sankara Nethralaya (2004). She also did a fellowship in Cornea, external diseases and uveitis at Francis.I.Proctor Foundation, University of California, San Franciso, USA (2011). She has presented several papers at national and international conferences. She was also a grant winner for IUSG 2009 Venice course. She has authored the atlas of “Uveitis and Scleritis” published in 2005. She is a member of American Uveitis Society (AUS). Currently, she works as a senior consultant in Uveitis and Cornea services at Medical Research Foundation,Sankara Nethralaya, Chennai, India.

Michal Kramer, MD, Head of Uveitis Service, Department of Ophthalmology, Rabin Medical Center, Israel, graduated from Hadassah School of Medicine, Hebrew University, Jerusalem, and completed her residency in the Department of Ophthalmology at Rabin Medical Center. Dr. Kramer had trained in Uveitis with Prof. Sue Lightman at Moorfields Eye Hospital in London, and had established the uveitis service at Rabin Medical Center, including the pediatric uveitis clinic at Schneider's Children Medical Center in Israel. Dr. Michal Kramer served as the first chair of the Israeli Uveitis Society (2009-2014. Her research interests involve clinical, imaging and genetic studies in uveitis; and the role of inflammation in other ocular pathologies. Currently, Dr. Michal Kramer is an active member in the International Uveitis Study Group (IUSG),  American Uveitis Society (AUS), the International Ocular Inflammation Society (IOIS), and the classification of uveitis diseases project (SUN2).

Prof. Rubens Belfort Jr is a Physician with specialization in Ophthalmology and Doctor in Medicine (Ophthalmology) and a PhD in Immunology. He holds also a MBA and is the Head Professor of the Department of Ophthalmology and Visual Sciences at the Federal University of Sao Paulo (UNIFESP) and President of the Vision Institute as well as The Brazilian Academy of Ophthalmology.
He was the Chairman of the Department and also the Coordinator of the Post Graduation Program in Vision Sciences and Ophthalmology of UNIFESP and President of the SPDM, the largest philanthropic Health Organization in Brazil.
He was also a fellow at the University of California in San Francisco and Visiting Scientist at the National Eye Institute NIH.
Rubens Belfort Jr is a member of the Brazilian Academy of Sciences, National Academy of Medicine, National Academy of Pharmacy the Brazilian Academy of Ophthalmology in Brazil and the Academia Ophthalmologica Internationalis.
He received the Order of the Scientific Merit from the Federative Republic of Brazil and has been a CNPq 1A investigator for over 15 years.
He was President of the World Ophthalmology Congress, Pan American Association of Ophthalmology, Chairman Pan American Foundation of Ophthalmology.
He is a officer of the International Council of Ophthalmology Foundation. He received the Chico Mendes, Jabuti, Scopus-Elsevier CAPES, Conrado Wessel and the American Academy of Ophthalmology Life Achievement Awards and the Duke Elder Award given by the World Ophthalmology Council and the Royal College of Ophthalmology.
He has given more than12 International named Lectures including the Jackson Memorial, The American Jounal of Ophthalmology and the Duke Elder and has concluded the tutorship of more than 80 postgraduate students.
He has more than 500 published papers which received 14438 citations resulting in a Google H index of 62 by July 2018.
His research activities are held in different parts of Brazil with emphasis in the Amazon, including the fields of infectious (such as Toxoplasmosis, AIDS, Zyka) and geriatric ocular diseases with clinical and epidemiological approaches trying also to increase medical access through new medical and social technologies.

Dr Jyotirmay Biswas is an ophthalmologist who has specialized in uveitis and ophthalmic pathology. He has done MBBS from Medical College, Calcutta and post graduation in ophthalmology from PGIMER, Chandigarh, fellowship in vitreoretinal surgery from Sankara Nethralaya.  He did two years fellowship in ophthalmic pathology from Doheny Eye Institute, University of Southern California, USA.

He has published 410 articles in peer reviewed journals, 47 chapters in books of ophthalmology.  He presented 32 papers in international conferences and 175 papers in national and state conferences. He had given 280 lectures in international and national conferences. He is reviewer of 36 Journals. He is a visiting professor at Advance Eye Care Center at PGIMER Chandigarh.

He has received 33 awards which includes Hari OM Ashram award for clinical research from Medical Council of India.

He is a member of International Uveitis Study Group. American Uveitis Society and executive council member of International Ocular Inflammation Society. He was the first to describe ocular lesions in AIDS in India. His current area of research is uveitis, AIDS and Eales' disease.

Currently he is working as director of uveitis and ophthalmic pathology departments at Sankara Nethralaya, Chennai. Dr Biswas also a marathon runner, recites Bengali poems and writes Bengali articles and received many awards.

Dr Chee is a Senior Consultant and heads both the Cataract Subspecialty Service and Ocular Inflammation and Immunology Service at the Singapore National Eye Centre (SNEC). She is also Professor, National University of Singapore and Duke-National University of Singapore Graduate Medical School, Singapore. In addition, to her clinical commitments, she serves as the group lead member of the Cataract research team at the Singapore Eye Research Institute. She graduated from the National University of Singapore, obtained her Masters there and became a Fellow of the Royal College of Surgeons, Glasgow, Edinburgh and College of Ophthalmologists, UK. In 1993, she completed her fellowship in Uveitis, and also in Oculoplastics, Lacrimal and Orbital Surgery at Moorfield’s Eye Hospital, London.

Her research interests are in Cytomegalovirus infection of the anterior segment, Ocular Tuberculosis, Dengue Maculopathy and Vogt-Koyanagi Harada disease. In cataract, she publishes on complicated cataracts and has special interest in developing new surgical techniques and instruments. She has published over 200 peer reviewed scientific papers and is a member of several editorial boards. She has made numerous presentations on uveitis and cataract, and run many teaching courses at regional and international meetings.

In 2000, she was given the Best Teacher Award in SNEC. She became an Asia Pacific Association of Cataract and Refractive Surgery Certified Educator (A.C.E) in 2005, and has received the American Academy of Ophthalmology Achievement award in 2007. In 2011, she took on the position of the Uveitis Chairman, International Council of Ophthalmology (ICO) Residency Curriculum Update Project and is appointed as an International council member of the IOIS International Council in Feb 2012. In April 2013, she was appointed President for Asia-Pacific Intraocular Inflammation Study Group (APIISG). She was conferred by SingHealth, the Outstanding Clinician 2011 Award and recently, the Singapore Health Quality Service Award 2014 (Gold) for her significant contributions. Most recently in Oct 2017, she was admitted as a fellow of the Academy of Asia-Pacific Professors of Ophthalmology (AAPPO).

Title: Prof. Dr.

Name: Joke de Boer

Position in organisation: ophthalmologist, head of the ophthalmo-immunology department, co-director ophthalmology training, medical advisor patient organisation for uveitis.

Bio sketch: Since 1995, ocular inflammation has been the focus of my clinical and scientific interest. The department of ophthalmology is Centre of Excellence for uveitis with approximately 5.000 patients in care. The department of ophthalmology has strong collaboration with the laboratory of translational immunology and department of virology of the UMC Utrecht to improve our efforts by implementing new treatment strategies for uveitis. My research interest focusses on development of personalized care for patient with chronic inflammatory eye diseases. I completed my doctorate degree in the "Analysis of intraocular fluids in uveitis" at The Dutch Ophthalmic Research Institute, The Royal Academy of Arts and Science, Amsterdam, under the supervision of professor Aize Kijlstra and professor Aniki Rothova. I participate in the Interdisciplinary working Group meetings for the therapy of pediatric uveitis, International Uveitis Study Group, the Dutch uveitis study group and chairman of the Dutch guideline for uveitis and addendum: TNF-α inhibitors  for uveitis. I authored and co-authored numerous peer-reviewed publications and congress abstracts. Over the past 10 years research funding and grants were received from several awarding bodies, including the recent funding for the research into the “Systems medicine in uveitis” and “Genetic immunological and functional aspect of uveitis associated with JIA". As ophthalmologist I participated in the multidisciplinary Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease. As a professional I am medical advisor for the Dutch patient organisation for uveitis.

Dr. Emmett T. Cunningham Jr. is currently Director of the Uveitis Service at California Pacific Medical Center; Adjunct Clinical Professor of Ophthalmology at Stanford University School of Medicine; Research Associate, The Francis I. Proctor Foundation, UCSF School of Medicine; Partner at West Coast Retina Medical Group; and Managing Director at Clarus, LLC.

Dr Cunningham is an internationally recognized authority in the field of infectious and inflammatory eye disease, having written over 350 publications and given over 400 presentations, including eight named lectureships. Dr. Cunningham was Clinical Professor and Director of the Uveitis service at NYU from 2002 to 2005 and was Director of both the Uveitis Service and the Kimura Ocular Immunology Laboratory at the University of California at San Francisco (UCSF) from 1995 to 2001.   Dr. Cunningham received an MD and MPH in epidemiology and statistics from Johns Hopkins University, and a PhD in neuroscience from the University of California at San Diego (UCSD) for work done at The Salk Institute.  He completed a residency in ophthalmology and fellowship training in Corneal Disease, External Disease and Uveitis at UCSF and The Francis I. Proctor Foundation, a medical retina and uveitis fellowship at Moorfields Eye Hospital in London, and a fellowship in public health ophthalmology at the Wilmer Eye Institute in Baltimore, Maryland.

Dr. Cunningham founded and is the Chairman of the Ophthalmology Innovation Summit (www.ophthalmologysummit.com), a well-attended symposium held in conjunction with the annual meetings of the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgeons, and the American Society of Retinal Surgeons.  The Ophthalmology Innovation Summit brings together leading companies, clinicians, academics and investors in the ophthalmology space. 

Dr. Cunningham is on the Board of The Alta Foundation, Annexon Biosciences, ViewPoint Therapeutics, SFJ Pharmaceuticals Group, and GrayBug Vision.  He served previously on the Boards of SARcode Biosciences (acquired by Shire) and Neomend (acquired by Bard).  He is currently a Board observer for Lumos and is on the Scientific Advisory Board of Aerie Pharmaceuticals.  Dr. Cunningham was a Board Observer for Ferrokin (acquired by Shire), Ophthotech (NASDAQ: OPHT), Pearl Therapeutics (acquired by AstraZeneca), and was a member of the Scientific Advisory Board for ESBATech (acquired by Alcon).  

Dr. Cunningham currently sees patients at West Coast Retina Medical Group, 1445 Bush Street, San Francisco, California 94109; TP# 415 972 4600; FAX # 415 975 0999; he may be contacted e-mail:  emmett_cunningham@yahoo.com .  His online profiles are available at:  http://www.proctor.ucsf.edu/faculty/emmett-t-cunningham-jr-md-phd-mph

Dr. Debra Anne Goldstein received her medical degree from McGill University in Montreal, Canada, where she subsequently completed an ophthalmology residency.  She then pursued a fellowship in uveitis and ocular immunology at McGill followed by a second fellowship in uveitis at the University of Illinois at Chicago. Dr. Goldstein has published over 150 papers in peer reviewed journals and has lectured widely all over the world.  She has done extensive investigator initiated and multicenter research. She has been the recipient of numerous awards and honors including the Senior Achievement Award from the American Academy of Ophthalmology, the Life Achievement Honor award from the American Academy of Ophthalmology, the AAO Secretariat Award for special contributions to the Academy, as well as an AOA clinical teaching award. She was twice awarded the Golden Apple Award for Best Teacher in Ophthalmology when she was a professor at the University of Illinois at Chicago.  In April of 2017 she was awarded the prestigious Magerstadt Professorship in Ophthalmology. Dr. Goldstein is currently the Magerstadt Professor of Ophthalmology as well as the Director of the Uveitis Service in the Department of Ophthalmology at Northwestern University’s Feinberg School of Medicine.

Professional career:

2012 - 2016:      Resident physician and researcher at the Institute for Medical Microbiology and Hygiene (University Hospital Tübingen; Prof. Autenrieth)

- Laboratory diagnostics of infectious diseases, bacterial resistances, hospital and environmental hygiene

- Vaccination and travel consultations for outpatients

- Clinical consultations and ward visits 

- Research project regarding microbiome and colonization resistance against opportunistic and highly resistant bacteria (German Center for Infection Research)

02/2012 to         Doctoral thesis (Dr. med.) at the Institute for Pathology regarding the EBV-associated

07/2015               Nasal NK-/T-Cell-Lymphoma (molecular/mutation analyses)

2016 - 2017:      Rotation: Institute for Medical Virology and Epidemiology of Viral Diseases (University Hospital Tübingen; Prof. Jahn)

2017 - 2018:      Rotation: Internal Medicine 1 (University Hospital Tübingen; Prof. Malek), specifically to the Department of Infectiology (Prof. Tacconelli)

- Care for infectiological patients, especially in the outpatient clinic for infectious diseases (HIV, tuberculosis, hepatitis B and C, chronic Q-fever et al.)

- Clinical studies doctor, especially regarding bloodstream infections, healthcare-associated and antibiotic-resistant bacterial infections, antimicrobial stewardship (including surveillance reports) and infection control (German Center for Infection Research)

2018 - now:       Continued work at the Institute for Medical Microbiology and Hygiene as well as in the Department of Infectiology of the University Hospital Tübingen

- Application for speciality approval in Medical Microbiology, Virology and Epidemiology of Infectious Diseases

Memberships: 

- Member of the DGHM (German Society for Hygiene and Microbiology) since 2014

chair of the Israeli Uveitis society

Dr. Zohar Habot-Wilner is the director of the uveitis & inflammatory eye disease service in the division of ophthalmology at the Tel Aviv Medical Center and a senior lecturer at the Sackler Faculty of Medicine at Tel Aviv University in Israel. She is the founder of the combined Rheumatology-Ophthalmology clinic for patients with systemic and ocular inflammatory diseases and a consultant at the retina unit in the division of ophthalmology at the Tel Aviv Medical Center. She graduated the Bruce Rappaport Faculty of Medicine at the Technion, Israel Institute of Technology, Haifa, Israel. She completed her residency in Ophthalmology at the Goldschleger Eye Institute at the Sheba Medical Center, Tel-Hashomer, Israel and a fellowship training in uveitis and external eye disease at Moorfields Eye Hospital in London, England.

Dr. Habot-Wilner main interests are uveitis, inflammatory eye diseases and retinal diseases. She is the chairman of the Israel Uveitis Society since 2016. She is the organizer of the ocular inflammatory disorders course, at the Lions Ophthalmology Educational Centre in Prague, Czech Republic and the organizer of the uveitis course at the School of Graduate Studies at the Sackler Faculty of Medicine at Tel Aviv University.

She participates in many scientific meetings, publishes peer-reviewed papers and book chapters and serves as an associate editor and reviewer in leading ophthalmology journals. She is an investigator in multicenter international studies and a member of several international professional societies, including the American Academy of Ophthalmology, the Association for Research in Vision and Ophthalmology, the American Uveitis Society, the International Ocular Inflammation Society and the International Uveitis Study Group. She is a member of the scientific council of the Israeli Ophthalmology Board Examinations.

Consultant Ophthalmologist and Director of Uveitis Service
Honorary Professor of Ophthalmology, MAHSC, University of Manchester
Manchester Royal Eye Hospital
Oxford Road
Manchester M13 9WL, UK

Nicholas Jones underwent his undergraduate training at the Universities of St. Andrews and Manchester, and postgraduate training in ophthalmology at Southampton and Manchester, UK. In 1991 he created the Manchester Uveitis Clinic, now in its 28th year and one of the busiest in the world, which has treated over 4,500 patients with uveitis from the North of England, Wales and beyond. He is the author of two textbooks: “Uveitis: An Illustrated Manual” which won the Royal Society of Medicine Book Prize in 1999, and “Uveitis: Second Edition” in 2012. He has also written a history of the Manchester Royal Eye Hospital for its bicentenary in 2014, numerous book chapters and over 100 peer-reviewed papers. The Manchester Uveitis Clinic team has a high research output; the main current interests are on the diagnosis and management of sarcoidosis and tuberculosis, on new imaging in uveitis, and on secondary glaucoma. Professor Jones is a member of the International Uveitis Study Group and the American Uveitis Society, is a founder faculty member of the Moorfields and Euretina Uveitis Courses, and is regularly invited to lecture and teach nationally and internationally. He is a member of the Editorial Boards of the journals Ocular Immunology & Inflammation, and Journal of Ophthalmic Inflammation and Infection.

Name:                 Nobuyoshi Kitaichi

Education           

        1993 M.D.           Hokkaido University School of Medicine

        2000 Ph.D.           Hokkaido University Graduate School of Medicine

Postdoctoral Training & Employment History

  ccademic Appointments:

ion:ships:

ool of Medicine

030-0022, Japan

1993                    Clinical Resident, Department of Ophthalmology, Hokkaido University Hospital

1996-2000           Doctor of Medical Science Course student

                            Department of Ophthalmology, Hokkaido University Graduate School of Medicine

2001                    Postdoctoral Research Fellow, Molecular Basis of Eye Diseases Training Program, Schepens Eye Research Institute, Harvard Medical School, Boston, MA, USA

2004                    JSPS* Research Fellow

                            *Japan Society for the Promotion of Science (Governmental fellowship)

2007          Assistant Professor & Chief Physician at Department of Ophthalmology, Hokkaido University Hospital

2010          Associate Professor, Department of Ophthalmology, Health Sciences University of   Hokkaido & Visiting Associate Professor, Hokkaido University Graduate School of Medicine

2013          Professor and Chairman, Department of Ophthalmology, Health Sciences University of Hokkaido & Visiting Professor, Hokkaido University Graduate School of Medicine

2017                  Director, Health Sciences University of Hokkaido Hospital

Biography – Professor Sue Lightman

Sue qualified in Medicine from the University of London.  After several years in internal medicine and general surgery, she went to Moorfields Eye Hospital to train as an ophthalmologist.  While undertaking a Fellowship in medical retina and neurophthalmology, Sue decided to pursue the subspecialty of intraocular inflammation and infection and was trained clinically and scientifically at the National Eye Institute in the USA.  On returning to the UK she became an MRC Senior Clinical Fellow/Senior Lecturer at the Institute of Ophthalmology and Consultant Ophthalmologist at Moorfields Eye Hospital where she set up the Uveitis Service.  She was appointed to the Duke Elder Chair in Ophthalmology in 1990 and to the University of London Chair in Ophthalmology in 1993, which she currently holds at UCL/Institute of Ophthalmology. 

She has a large uveitis clinical work load which includes adult uveitis clinics, paediatric uveitis clinic, a multidisciplinary vasculitis clinic and clinical trials clinics. She is a member of the MUST clinical trials group and recruited patients for the MUST and POINT trials and currently for the MERIT trial. Fellows come from all over the world to be trained in the diagnosis and management of all aspects of ocular inflammatory disease.  In addition she runs an active clinical research programme which includes many ophthalmologists undertaking higher degrees (MD (Res) and PhD).  She has published nearly 400 papers and supervised over 40 higher degrees in Ophthalmology.  Sue is Director of Clinical Education at the UCL/Institute of Ophthalmology and has hugely expanded the teaching/learning opportunities available for ophthalmologists and allied medical professionals.  She currently runs 1 and 2 year Masters courses at the Institute of Ophthalmology in Clinical Ophthalmology as well as many CPD courses and lectures nationally in the UK and internationally in the field of ocular inflammation.  In this last year she has been awarded 3 international prizes for her work in this field.

Marion R. Munk is a trained MD, PhD, Assistant Professor and Uveitis and Medical Retina specialist at the Inselspital, University Clinic Bern in Switzerland and Managing director at the Bern Photographic Reading Center. She is also adjunct Lecturer at the Northwestern University, Chicago, USA, where she previously was a research fellow in Medical retina. Marion R Munk is the author and co-author of numerous scientific articles and book chapters. Her major research interests cover image processing, image analyses, posterior uveitis and macular diseases. She is a member of the Editorial Board of the journals IOVS, Acta Ophthalmologica and BMC Ophthalmology, and in addition she is providing peer-review for a long list of scientific journals within Ophthalmology.

Philip I. Murray MBBS, DO(RCS), PhD, FRCP, FRCS, FRCOphth undertook most of his clinical ophthalmology training at Moorfields Eye Hospital, London and his basic science laboratory training at the Institute of Ophthalmology, London and the Department of Ophthalmo-Immunology, Amsterdam.

He is Professor of Ophthalmology, Institute of Inflammation and Ageing, University of Birmingham. His laboratory research is focussed on understanding:

•    why intraocular tolerance fails in uveitis?|
•    what immune mechanisms initiate and drive the inflammatory response?
•    what can one do about it?

He is Honorary Consultant Ophthalmologist at the Birmingham and Midland Eye Centre (BMEC), Sandwell and West Birmingham Hospitals NHS Trust and runs 2 dedicated regional/supra-regional uveitis clinics per week. He enjoys the challenging and frustrating nature of uveitis but also finds it immensely rewarding. He is involved in clinical trials on novel therapies for uveitis and until recently he had a special interest in cataract surgery on the uveitic eye. He is part of the Birmingham National Centre of Excellence for Behçet’s Syndrome.

From 2004-2016 he was Secretary of the International Uveitis Study Group. He sits on numerous national committees, is Section Editor for three Journals, Examiner for the Royal College of Ophthalmologists and External Examiner for the Royal College of Surgeons of Ireland and Past External Examiner, Optometry BSc (Hons), Aston University.

He has published over 180 peer-reviewed papers, contributed numerous book chapters and authored four textbooks, including the highly successful ‘Oxford Handbook of Ophthalmology’. He has a keen interest in undergraduate ophthalmology teaching (previously national lead for the RCOphth), an adviser to three national uveitis patient groups, helped set up a successful local patient involvement group in uveitis and an advocate of ‘The Patient Voice’.

He is a fervent supporter of English Championship side, Brentford FC and plays baritone sax in Out Of The Blue Big Band and The Soul Providers (www.pimurray.com).

James T. Rosenbaum is the head of the division of Arthritis and Rheumatic Diseases at Oregon Health & Science University and Chair of Ophthalmology at Legacy Devers Eye Institute. Both are in Portland, Oregon. He holds the Edward E Rosenbaum Chair in Inflammation Research at OHSU and the Richard Chenoweth Chair at the Devers. His awards include the Friedenwald Award from ARVO, the Gold Medal from the IUSG Foundation, and the Clinician Scholar and Master Awards from the American College of Rheumatology.

Dr. Manabu Mochizuki, MD, PhD completed residency in ophthalmology at Tokyo University Hospital, assigned Associate Professor, Department of Ophthalmology, Tokyo University; Professor & Chairman, Department of Ophthalmology, Kurume University; Professor & Chairman, Department of Ophthalmology & Visual Science, Tokyo Medical and Dental University, and Emeritus Professor at present. He is a founding member of IOIS, and served as Chairman and General Secretary of the society. He is an active member of IUSG, AUS, ISER and a Gold fellow of ARVO. He was the President of Japanese Ocular Inflammation Society and Japanese Ocular Pharmacological Society, Council of Japan Ophthalmological Society.